Cancer prevention from the perspective of global cancer burden patterns.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 28449441)

Published in J Thorac Dis on March 01, 2017

Authors

Hiroki Nagai1,2, Young Hak Kim2

Author Affiliations

1: Department of Clinical Oncology, Kyoto University Hospital, Japan.
2: Department of Respiratory Medicine, Kyoto University Hospital, Japan.

Articles cited by this

Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med (2011) 38.61

Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med (2003) 35.39

Helicobacter pylori infection and gastric lymphoma. N Engl J Med (1994) 10.26

HPV vaccine against anal HPV infection and anal intraepithelial neoplasia. N Engl J Med (2011) 4.69

Efficacy of human papillomavirus-16 vaccine to prevent cervical intraepithelial neoplasia: a randomized controlled trial. Obstet Gynecol (2006) 4.33

Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet (2016) 3.31

Human papillomaviruses. IARC Monogr Eval Carcinog Risks Hum (2007) 3.30

Obesity, body size, and risk of postmenopausal breast cancer: the Women's Health Initiative (United States). Cancer Causes Control (2002) 3.27

Physical activity and colon cancer prevention: a meta-analysis. Br J Cancer (2009) 3.13

Meta-analysis: can Helicobacter pylori eradication treatment reduce the risk for gastric cancer? Ann Intern Med (2009) 3.12

Evaluation of human papillomavirus antibodies and risk of subsequent head and neck cancer. J Clin Oncol (2013) 2.87

Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer. N Engl J Med (1999) 2.79

Efficacy of neonatal HBV vaccination on liver cancer and other liver diseases over 30-year follow-up of the Qidong hepatitis B intervention study: a cluster randomized controlled trial. PLoS Med (2014) 2.74

Hepatitis C virus genotype 1b as a major risk factor associated with hepatocellular carcinoma in patients with cirrhosis: a seventeen-year prospective cohort study. Hepatology (2007) 1.98

Physical activity and cancer prevention: from observational to intervention research. Cancer Epidemiol Biomarkers Prev (2001) 1.91

Non-alcoholic fatty liver disease progresses to hepatocellular carcinoma in the absence of apparent cirrhosis. Int J Cancer (2011) 1.89

Global cancer patterns: causes and prevention. Lancet (2013) 1.67

Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015: A Systematic Analysis for the Global Burden of Disease Study. JAMA Oncol (2016) 1.65

Height, body mass index, and ovarian cancer: a follow-up of 1.1 million Norwegian women. J Natl Cancer Inst (2003) 1.55

Cessation of alcohol drinking, tobacco smoking and the reversal of head and neck cancer risk. Int J Epidemiol (2009) 1.22

Tobacco addiction: implications for treatment and cancer prevention. J Natl Cancer Inst (1997) 1.05

Aiming High--Changing the Trajectory for Cancer. N Engl J Med (2016) 0.85

Causal role of Helicobacter pylori infection in gastric cancer. World J Gastroenterol (2006) 0.84